VerwilstLab
Part of the Medicinal Chemistry division
at the Rega Institute for Medical Research
of KU Leuven
at the Rega Institute for Medical Research
of KU Leuven
Medicinal Chemistry
Small-molecule drug design
Neurodegenerative Diseases
Drugs and fluorescent markers for neurodegenerative diseases
Novel Antimicrobials
Drug design of novel antibacterials, antivirals and antiparasitics
Enzyme Targets
Allosteric modulation of enzyme targets
Receptors
Allosteric modulation of receptor signalling
Researchers
Peter Verwilst
PI
Eline Goffin
PhD Student
Margaux Billen
PhD Student
Radu Bulai
PhD Student
Xujie Zhang
PhD Student
Lijun Yang
PhD Student
Yunong Zhang
PhD Student
Laurynn Torfs
Master's Student
Jesper Allaer
Master's Student
Sam Purnal
Master's Student
Congratulations Margaux!
Congratulations on the publication of our latest review! Link
Welcome Maria Cremonini
Maria joined the lab as an ERASMUS+ student and will be strengthening our FabV drug design research team. We wish you a pleasant stay in Leuven and an excellent experience in the lab.
Covid Safe Christmas/Grant Drink
Merry Christmas and a Happy Healthy 2022!
Welcome Edoardo Rocca
Edoardo joined the lab as an ERASMUS+ trainee. We wish you a great stay in Leuven and an exciting research experience.
Welcome to our new PhD student Sofie Heylen
Sofie previously joined our lab as a Master's student and will now work towards a PhD. Welcome back, Sofie!
Sofie will research new avenues to combat antimicrobial drug resistance focusing on the microbial fatty acid synthesis pathways.
Welcome to our new Master's students
Simon Wilms and Nele Theysmans will be joining the team. We wish them both a great experience in the lab!
Simon will be working on developing novel NNRTIs inhibiting HIV, Nele will be exploring structure-based drug design on a polyoma virus target.